Stock screenerAll disclosures →
EDGAR →
STTK
Conviction 100HealthcareScan · Mon, Aug 10, 2026Bearish marubozu
STTK$7.14-1.86%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.12M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price7.14
Change-1.86%
Gap+2.06%
Rel volume3.13×
Avg volume1.37M
Avg $ vol9.82M
SMA 207.11
SMA 506.21
SMA 2004.97
Price vs 50+14.80%
Price vs 200+43.51%
MA stackbullish
50/200 cross—
Supertrendup · 5.89
RSI (14)53
MACD hist-0.04
MACD crossbear · 2d
Stoch %K / %D42 / 46
ADX (14)29
+DI / −DI22 / 14
RSI divergence—
MACD divergence—
ATR %+7.75%
ADR %8.07%
52w high7.92
52w low0.7392
From 52w high-9.91%
Above 52w low+865.23%
New 52w highNo
SqueezeOn · 13d
Bollinger width18.55%
%B0.52
Donchian pos57.18%
Donchian high7.94
Donchian low6.06
AVWAP (52w high)6.30
vs AVWAP high+13.26%
AVWAP (52w low)4.68
vs AVWAP low+52.53%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d3.13×
Avg vol (14d)1.12M
Avg vol (20d)1.37M
Avg $ vol (20d)9.82M
Market cap547.12M
RS 3m (vs SPY)+10.44%
RS 6m (vs SPY)+89.53%
RS line new highNo
Trend template8/8
Technical rank85.8
1 week-2.13%
1 month+7.45%
3 months+4.16%
6 months+89.26%
1 year+813.69%
YTD+92.32%
P/E-11.21
P/B5.71
P/S547.12
P/FCF-13.69
EPS-0.7000
Div yield—
ROE-50.93%
ROA-47.80%
Debt/Eq—
Current22.06
EV/EBITDA-9.55
Gross margin—
Net margin—
Rev growth-82.52%
EPS growth35.28%
Price target15.75
Target upside120.74%
Analyst ratingBuy
Institutional73.36%
Ent. value456.7M
Revenue0
Net income-14.77M
Gross profit—
Free cash flow-39.95M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out76.68M
Employees40
ListedFri, Oct 9, 2020
Free float53.77M
Float %71.3%
Short interest7.8M
Days to cover5.8d
Short volume25.9%
Squeeze score69 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.13 vs −$0.14
Last surprise+7.1% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank85.8 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish marubozu
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 24 – Aug 32 scans
- Breaking out nowAug 41 scan
Congress activity
Disclosed STOCK Act trades in STTK
No recent disclosed trades by Congress in STTK. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in STTK · 4 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shukla Abhinav A. Chief Technical Officer · Stock Option (Right to Buy) · 2026-07-06 | Exercise | 12.15K | — | 2026-07-06 | 2026-07-07 |
Shukla Abhinav A. Chief Technical Officer · Common Stock · 2026-07-06 | Exercise | 12.15K | $43K | 2026-07-06 | 2026-07-07 |
Shukla Abhinav A. Chief Technical Officer · Stock Option (Right to Buy) · 2026-07-02 | Exercise | 410 | — | 2026-07-02 | 2026-07-07 |
Shukla Abhinav A. Chief Technical Officer · Common Stock · 2026-07-02 | Exercise | 410 | $1K | 2026-07-02 | 2026-07-07 |
Shukla Abhinav A. Chief Technical Officer · Common Stock · 2026-07-02 | Sell | 410 | $3K | 2026-07-02 | 2026-07-07 |
OrbiMed Capital GP IX LLC Director · Pre-Funded Warrants (right to buy) · 2026-06-08 | Convert | 3.07M | — | 2026-06-08 | 2026-06-09 |
OrbiMed Capital GP IX LLC Director · Common Stock · 2026-06-08 | Other | — | — | 2026-06-08 | 2026-06-09 |
OrbiMed Genesis GP LLC Director · Common Warrants (right to buy) · 2026-06-08 | Convert | 15.37M | — | 2026-06-08 | 2026-06-09 |
OrbiMed Capital GP IX LLC Director · Common Warrants (right to buy) · 2026-06-08 | Convert | 15.37M | — | 2026-06-08 | 2026-06-09 |
OrbiMed Genesis GP LLC Director · Pre-Funded Warrants (right to buy) · 2026-06-08 | Convert | 3.07M | — | 2026-06-08 | 2026-06-09 |
SEC filings
EDGAR filings in STTK · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.